Study: Prostate cancer focal therapy is cost-effective and may improve patient outcomes

Minimally invasive focal therapies for prostate cancer are associated with a lower overall cost and improved quality of life for patients.

Leave A Comment

Your email address will not be published. Required fields are marked *